[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.237.138.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 13,301
Citations 0
Viewpoint
May 21, 2020

Innovation in Home Care: Time for a New Payment Model

Author Affiliations
  • 1Philadelphia VA Medical Center, Philadelphia, Pennsylvania
  • 2Perelman School of Medicine, Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia
  • 3Wharton School, Department of Health Care Management, University of Pennsylvania, Philadelphia
  • 4Humana Inc, Louisville, Kentucky
JAMA. 2020;323(24):2474-2475. doi:10.1001/jama.2020.1036

Much of the greatest innovation in industries other than health care deploys technology-enabled approaches to making services more accessible and convenient and lower cost or higher quality. For example, companies such as Blockbuster Video, which provided what seemed like essential services, was supplanted by Netflix, which offered on-demand, personalized viewing of videos from the convenience of home. Uber and Lyft have become quite popular, replacing hailing a taxicab. Similarly, in health care there has been a shift toward provision of home services, with substantial growth in areas such as provision of home infusion therapy and remote monitoring of blood glucose levels. The current coronavirus disease 2019 (COVID-19) pandemic has accelerated this shift because care in the home can reduce exposure to potentially infected individuals and help address capacity constraints in health care facilities. However, a common concern has been that payment models have not supported this type of innovation.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×